Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Experimental and Therapeutic Medicine|July 2, 2019
Efficacy of long-term treatment with tenofovir in Chinese nucleos(t)ide-naïve chronic hepatitis B patients regardless of baseline viral loadJie Luo, Xu You, Yutian Chong, et al.Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 1, 2014
[Efficacy of 48-week tenofovir disoproxil fumarate therapy in patients who were unresponsive to nucleoside-analogue treatments]Mingxing Huang, Xinhua Li, Yuankai Wu, et al.Clinics and Research in Hepatology and Gastroenterology|November 25, 2015
Comprehensive analysis of hospital-based prospective cohort reveals the unique effectiveness and safety for nucleos(t)ide analogues in HBV patientsYuankai Wu, Yusheng Jie, Xiangyong Li, et al.Hepatology International|March 5, 2020
The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysisYuankai Wu, Qi Zheng, Biyao Zou, et al.Gastroenterology|May 16, 2025
Associations of Alcohol Consumption and Genetic Predisposition to Hepatic Steatosis With Liver-Related Events: Results From Large Population-Based Cohort StudiesHongliang Xue, Liqing Wang, Dianjianyi Sun, et al.Functional & Integrative Genomics|January 11, 2025
Unraveling the potential mechanism and prognostic value of pentose phosphate pathway in hepatocellular carcinoma: a comprehensive analysis integrating bulk transcriptomics and single-cell sequencing dataBin Li, Tao Zeng, Cui Chen, et al.Journal of Hepatology|April 11, 2023
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 personsMichael H Le, David M Le, Thomas C Baez, et al.Clinical and Molecular Hepatology|January 28, 2024
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysisMichael H Le, David M Le, Thomas C Baez, et al.The Lancet. Gastroenterology & Hepatology|May 16, 2020
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysisQing Ye, Biyao Zou, Yee Hui Yeo, et al.The Lancet. Oncology|June 20, 2015
A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control studyXue-Jia Lin, Yutian Chong, Zhi-Wei Guo, et al.Pageof 6